Combination drug treatment of beingn prostatic hyperplasia (BPH

dc.contributor.author	Oliech, JS
dc.date.accessioned	2013-04-22T12:55:54Z
dc.date.available	2013-04-22T12:55:54Z
dc.date.issued	2010
dc.identifier.citation	The Annals of African Surgery, (2010)	en
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16498
dc.description.abstract	Combination use of alpha-adrenergic blockers (tamsulocin or alfuzocin) and 5 alpha iso-enzyme 1&2 inhibitor (dutasteride) in symptomatic benign prostatic hyperplasia (BPH) is the best first optional mode of treatment giving good results with minimal treatment adverse effects especially for those at risk for surgical intervention and those who are still sexually active.	en
dc.language.iso	en	en
dc.title	Combination drug treatment of beingn prostatic hyperplasia (BPH	en
dc.type	Article	en
local.publisher	Department of Surgery	en